Evolent Health, Inc. (EVH) stock
EVHNYSEServices-Management ServicesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3065% below fair value
$3.93−0.69 (-14.94%)
Close on Nov 18, 2026Market cap $444.32MP/E –Yield –
Evolent Health free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Evolent Health's free cash flow for the twelve months ending Dec 31, 2019 was -$78.18M. For fiscal 2019 it was -$78.18M. The highest annual figure on record is $0 in fiscal 2014.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | -$78.18M | – |
| FY2018 | Dec 31, 2018 | -$60.20M | – |
| FY2017 | Dec 31, 2017 | -$55.81M | – |
| FY2016 | Dec 31, 2016 | -$51.04M | – |
| FY2015 | Dec 31, 2015 | -$24.98M | – |
| FY2014 | Dec 31, 2014 | $0 | – |
| FY2013 | Dec 31, 2013 | -$24.07M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2019 | Dec 31, 2019 | $4.03M | – |
| Q3 FY2019 | Sep 30, 2019 | -$25.23M | -287.6% |
| Q2 FY2019 | Jun 30, 2019 | -$21.81M | – |
| Q1 FY2019 | Mar 31, 2019 | -$35.17M | – |
| Q4 FY2018 | Dec 31, 2018 | -$35.40M | – |
| Q3 FY2018 | Sep 30, 2018 | $13.45M | – |
| Q2 FY2018 | Jun 30, 2018 | -$3.99M | – |
| Q1 FY2018 | Mar 31, 2018 | -$34.26M | – |
| Q4 FY2017 | Dec 31, 2017 | -$464.00K | – |
| Q3 FY2017 | Sep 30, 2017 | -$5.10M | -225.7% |
| Q2 FY2017 | Jun 30, 2017 | -$9.50M | – |
| Q1 FY2017 | Mar 31, 2017 | -$40.74M | – |
| Q4 FY2016 | Dec 31, 2016 | -$25.92M | – |
| Q3 FY2016 | Sep 30, 2016 | $4.06M | – |
See a number that looks wrong?